Objective Biotechnology Overview
- Year Founded
-
2023
- Status
-
Private
- Employees
-
10
- Latest Deal Type
-
Angel
- Latest Deal Amount
-
$60K
- Investors
-
4
Objective Biotechnology General Information
Description
Operator of a biotechnological company intended to develop high-impact technologies that enable comprehensive measurement and manipulation of biological systems. The company offers an automated microinjection system, neurotechnology tools such as cortex-wide optical access and neural recordings, a miniature wide-field microscope, a cranial-microsurgery platform, and more, enabling the healthcare industry to carry out high-throughput transgenesis or mutagenesis experiments and minimize staff training and hands-on time.
Contact Information
Website
www.objectivebiotechnology.comCorporate Office
- 225 Thomas Avenue North
- Suite 50
- Minneapolis, MN 55405
- United States
Corporate Office
- 225 Thomas Avenue North
- Suite 50
- Minneapolis, MN 55405
- United States
Objective Biotechnology Timeline
Objective Biotechnology Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 5. Angel (individual) | 31-Mar-2025 | $60K | Completed | Generating Revenue | ||
| 4. Seed Round | 05-Oct-2024 | Completed | Generating Revenue | |||
| 3. Grant | 15-Mar-2024 | Completed | Generating Revenue | |||
| 2. Grant | 01-Jan-2024 | $295K | Completed | Startup | ||
| 1. Grant | 01-Jan-2024 | $25K | Completed | Startup |
Objective Biotechnology Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Objective Biotechnology Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Objective Biotechnology Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Objective Biotechnology Investors (4)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Gopher Angels | Angel Group | Minority | ||
| Walleye Tank | Other | |||
| Minnesota Cup | University | |||
| NIH Office of the Director | Government |
Objective Biotechnology FAQs
-
When was Objective Biotechnology founded?
Objective Biotechnology was founded in 2023.
-
Where is Objective Biotechnology headquartered?
Objective Biotechnology is headquartered in Minneapolis, MN.
-
What is the size of Objective Biotechnology?
Objective Biotechnology has 10 total employees.
-
What industry is Objective Biotechnology in?
Objective Biotechnology’s primary industry is Discovery Tools (Healthcare).
-
Is Objective Biotechnology a private or public company?
Objective Biotechnology is a Private company.
-
What is Objective Biotechnology’s current revenue?
The current revenue for Objective Biotechnology is .
-
How much funding has Objective Biotechnology raised over time?
Objective Biotechnology has raised $775K.
-
Who are Objective Biotechnology’s investors?
Gopher Angels, Walleye Tank, Minnesota Cup, and NIH Office of the Director have invested in Objective Biotechnology.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
